TO STUDY THE ROLE OF NASAL DROPS OF TIL TAILA ON SLEEP
Phase 3
- Registration Number
- CTRI/2021/04/033254
- Lead Sponsor
- Dr Vishakha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Healthy individuals of age group between 18-60 years.
Exclusion Criteria
Subjects below 18 years and above 60 years.
Pregnancy
Indigestion
Fever
Alcoholic
Obese
Suffering from any severe CNS disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie TIL TAILA Nasya's effects on sleep regulation pathways?
How does TIL TAILA Nasya compare to benzodiazepines in improving sleep latency and quality?
Are there specific biomarkers like melatonin levels or circadian rhythm markers predictive of TIL TAILA Nasya response?
What adverse events are associated with Ayurvedic nasal formulations like TIL TAILA in sleep trials?
What combination therapies with TIL TAILA Nasya are being explored for insomnia treatment in clinical research?